11C-BMS-986196
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 11C-BMS-986196, covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis [Phase 1]